Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction

Journal of Cardiology

Volumn 49, Issue 3, 2007, Pages 135-141

  Hara, Hitoshi ^a,b   Horinaka, Shigeo ^a   Yabe, Akihisa ^a   Yagi, Hiroshi ^a   Tsuboko, Yusuke ^a   Yoshida, Kotaro ^a   Iemura, Tomomi ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b DOKKYO UNIVERSITY   (Japan)

Author keywords

Interventional cardiology; Myocardial infarction; Treatment; Ventricular arrhythmia U Drug therapy (nicorandil)

Indexed keywords

NICORANDIL; PLACEBO; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CORONARY REPERFUSION; DRUG EFFECT; DRUG INFUSION; HEART BEAT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NICORANDIL; TACHYCARDIA, VENTRICULAR;

EID: 34249679277     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ueda H, Nakayama Y, Tsumura K, Yoshimaru K, Hayashi T, Yoshikawa J: Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction. Can J Cardiol 2004; 20: 625-629.
2. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hod M, Higashino Y, Fujii K, Minamino T: Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wail myocardial infarction. J Am Coil Cardiol 1999; 33: 654-660.
3. Kamijo T, Kamei K, Sugo T,Kamiyama T, Sudo H, Ohba Y: Hernodynamic and hormonal responses to nicorandil in canine model of acute ischemic heart failure: A comparison with cromakalim and nitoroglycerin. J Cardiovasc Pharmacol 1999; 33: 93-101.
4. Nakae I, Quan L, Hashimoto K, Sugimoto Y, Tsutamoto T, Kinoshita M: Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs. Cardiovasc DrugsTher 1994; 8: 137-145.
5. Ikeda N, Yasu T, Kubo N, Hashimoto S. Tsuruya Y, Fujii M, Kawakami M, Saito M: Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart 2004; 90: 181- 185.
6. Ishii H, Ichimiya 5, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T: Impact of a single administration of nicorandil before reperfusion in patients with STsegment-elevation myocardial infarction. Circulation 2005; 112: 1284-1288.
7. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A, for the The GUSTO Investigators: Sustained ventricular arrhythmia in patients receiving thrombolytic therapy: Incidence and outcomes. Circulation 1998; 98: 2567-2573.
8. Itoh T, Fukami K, Suzuki T, Aoki H, Ohira K, Satoh N, Shibata M, Ohsawa M, Suzuki T, Nakamura M: Effect of pre-myocardial infarction angina pectoris on post-myocardial infarction arrhythmias after reperfusion therapy. Am 3 Cardiol 2006; 97: 1157-1161.
9. Keeley EC, Boura JA, Grines GL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
10. Naccarelli GV, Woibrette DL, Dell'Orfano JT, Patel HM, Luck JC: A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: From CAST to AVID and beyond: Cardiac Arrhythmic Suppression Trial: Antiarrhythmic Versus Implantable Defibrillators. J Cardiovasc Electrophysiol 1998; 9: 864-891.
11. Noma A: ATP-regulated K + channels in cardiac muscle. Nature 1983; 305: 147- 148.
12. + channels protect the myocardium against ischemialreperfusion damage. Circ Res 1991; 69: 571-581.
13. + loss and arrhythmias in rat heart: Effect of gilbenclamide, a sulfonylurea. Circ Res 1990; 66: 478.
14. Wolleben CD, Sanguinetti MC, Siegel PK: Influence of ATP-sesitive potassium channel modulators on ischemiainduced fibrillation in isolated rat hearts. J Mol Cell Cardiol 1989; 21: 783-788.
15. Shaw RNI, Rudy Y: Electrophysiologic effects of acute myocardial ischemia: A theoretical study of altered cell excitability and action potential duration. Cardiovasc Res 1997; 35: 256-272.
16. Miyazaki T, Moritani K, Miyoshi S. Asanagi S. Zhao LS, Mitamura H, Ogawa S: Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia. J Cardiovasc Pharmacol 1995; 26: 949-956.
17. Shinohara H, Nishikado A, Vakatsuki T, Sakabe K, Ito S: The effects of nicorandil on electrophysiological changes in acute myocardial ischemia and reperfusion. Jpn Heart J 1998; 39: 363-373.
18. Fox, JJ. McHarg JL, Gilmour RF Jr: Ionic mechanism of electrical alternans. Am J Physiol Heart Circ Physiol 2002; 282: H516-H530.
19. Ito S, Miyazaki T, Miyoshi S. Furukawa Y, Takagi S, Moritani K, Mitamura H, Ogawa 5: Ventricular fibrillation and shortening, alternans and after-depolarizations of epicardial monophasic action potentials during coronary occlusion and reperfusion: Effect of repetition of ischemia. Jpn Circ J 1999; 63: 201-208.
20. Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, Kanatsuka H, Shirato K : Vasodilatory effect of nicorandil on coronary arterial microvessels: Its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1995; 26: 541-547.
21. Mizunuma T, Nithipatikom K, Gross GJ: Effect of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995; 29: 482-489.
22. Klein HH, Pich 5, Lindert-Heimberg S. Shade-Brittinger C, Maisch B, Nebendahl K: Comparative study on the effects of intracoronary nicorandil and nitoroglycerin in ischaemic, reperfused porcine hearts. Eur Heart J 1995; 16: 603-609.
23. Pieper GM, Gross GJ: Anti-free-radical and neutrophil modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 1992; 6: 225-232.
24. Semi S, Helmut N, Gunther B, Klaus N, Thomas G, Gisela D: Beneficial effects of nicorandil in acute myocardial infarction: A placebo-controlled, double-blind pilot safety study. The British Journal Cardiology 1998; 5: 208-220.